Features
Towards the next generation of computing devices
20 November 2020Computing devices are finally reaching their limits. But recently discovered particles called magnetic skyrmions could redefine these limits, according to Anjan Soumyanarayanan.
Assuring asymptomatic COVID-19 carriers are identified
6 November 2020A*STAR researchers have developed a point-of-care rapid antibody test kit that can detect antibodies produced in response to SARS-CoV-2 infection in just fifteen minutes.
Sensing emotions in a crisis
30 October 2020Multidimensional emotion-sensing algorithms that analyze social media for the public’s concerns during times of crisis could help improve policy and messaging from governments.
Streamlining COVID-19 screening for success
23 October 2020By eliminating bottlenecks and automating manual processes, the RESOLUTE test kit and RAVE system co-developed by A*STAR scientists will help give COVID-19 testing a much-needed boost.
Dissecting movement disorders through the eyes of a fly
12 October 2020In the search for new therapeutics and diagnostic tools, Sherry Aw is unraveling the biology behind movement disorders using the humble fruit fly.
Staying ahead of the (infection) curve
30 September 2020Serology testing may be fast and easy to perform, but there are still some limitations that need to be overcome, suggests Laurent Renia.
Placing a ‘hit’ on the crown
11 September 2020Could there be a drug that can both treat and protect against COVID-19? The answer may be found in antibody drugs, a promising therapeutic modality against the coronavirus.
Identifying antibodies that work
9 September 2020A new test manufactured by A*STAR’s Diagnostics Development Hub in partnership with Duke-NUS Medical School could reveal if an individual is likely immune to COVID-19.
Bioinformatics: At the forefront, behind the scenes
4 September 2020Sebastian Maurer-Stroh shares how bioinformatics has enabled Singapore to respond quickly to COVID-19 and will continue to play an important role in ongoing surveillance.
The mutation making COVID-19 milder
24 August 2020Scientists at A*STAR have found that a mutation in SARS-CoV-2 called ∆382 leads to milder clinical outcomes, with implications for COVID-19 treatments and vaccines.
Finding the ideal disinfection agent
7 August 2020Regular disinfection can help to limit the spread of viral infections such as COVID-19, but only if carried out appropriately, write Xian Jun Loh and colleagues.
Taming abnormal blood vessel growth
29 July 2020Uttam Surana shares how SiNOPSEE Therapeutics, the biopharmaceutical startup he co-founded, is developing drugs to block angiogenesis in cancer and degenerative eye conditions.
The fast track to Fortitude
27 July 2020In a display of scientific willpower, A*STAR researchers developed and deployed the COVID-19 diagnostic Fortitude Kit within weeks of the virus reaching Singapore’s shores.
